Chest Pain in Men: How Cardiologists Tell Cardiac from Non-Cardiac

Chest pain is one of the most common reasons men present to emergency departments and urgent care clinics. For the clinician on the other side of the curtain, the question is almost always the same: is this the heart, or is this something else? Getting that question wrong in either direction carries consequences. Miss a cardiac cause and a man leaves the building mid-infarction. Over-investigate a benign cause and you expose him to unnecessary procedures, radiation, and anxiety.

The differential is broad. The evidence shows the most important early task is not to diagnose the specific non-cardiac cause, but to confidently rule in or rule out a cardiac etiology before pursuing other explanations.

How Men Typically Present with Cardiac Chest Pain

Men more often present with what clinicians call “classic” ischemic chest pain: a heavy, pressure-like, or crushing discomfort that is substernal, central in the chest, and may radiate to the left arm, jaw, or both shoulders simultaneously. Patients frequently describe it as an “elephant on the chest” or something pressing from the inside. This description, when combined with exertional provocation and relief with rest or nitrates, substantially raises the pre-test probability of coronary artery disease.

Each of the following features independently increases the probability of myocardial ischemia when present:

Substernal or central location rather than lateral or positional. Pressure or heaviness rather than sharpness or stabbing. Radiation to the left arm, jaw, both shoulders, or the neck. Onset or worsening with physical or emotional exertion. Relief within minutes of rest. Associated diaphoresis, particularly cold and clammy sweating. Nausea or vomiting accompanying the chest discomfort.

When three or more of these features are present in a middle-aged or older man with cardiovascular risk factors, some cardiologists treat the presentation as ischemia until proven otherwise, regardless of what the initial ECG shows.

That said, approximately 30 to 40 percent of men with confirmed acute coronary syndrome (ACS) present with atypical features. Sharp pain, pain that is reproduced with movement, pain that is pleuritic, and pain localized to a small area of the chest wall can all occur in the context of a real myocardial infarction. This is the clinical trap that leads to missed diagnoses, particularly in younger men who are assumed to be low risk.

Non-Cardiac Causes and How to Recognize Them

Understanding the non-cardiac causes of chest pain is not simply a matter of reassurance. It is a systematic process of identifying features that increase the probability of benign etiologies while being careful not to use those features as definitive exclusions of cardiac disease.

Musculoskeletal Chest Pain

Musculoskeletal causes account for approximately 20 to 30 percent of chest pain presentations in primary care and emergency settings. The most common entity is costochondritis, which involves inflammation at the costochondral or costosternal junctions. The pain is typically well-localized, sharp, and reproducible with direct palpation over the affected joint.

The evidence shows that reproducible chest wall tenderness on palpation carries a likelihood ratio of approximately 2.7 for musculoskeletal etiology. This is a modest finding, meaning it shifts probability somewhat but does not exclude cardiac disease. Importantly, some men with active myocardial ischemia also have reproducible tenderness, possibly because referred pain sensitizes the chest wall. For this reason, a positive palpation test alone should not terminate cardiac evaluation in a man with risk factors.

Other musculoskeletal causes include rib fractures from trauma or pathological bone disease, intercostal muscle strain from unusual exertion or coughing, and Tietze syndrome, which is a less common condition involving visible swelling at the costochondral junction. These typically have a clear precipitating event in the history, such as heavy lifting, a recent viral illness with prolonged coughing, or direct chest wall trauma.

GERD and Esophageal Causes

Gastroesophageal reflux disease is among the most common non-cardiac mimics of cardiac chest pain. The discomfort is typically burning in quality, located in the substernal or epigastric region, and worsened after large meals, fatty foods, alcohol, or in the supine position. Relief with antacids or in the upright position is a useful clinical clue, though not pathognomonic.

What makes esophageal chest pain particularly tricky is esophageal spasm. Esophageal spasm can produce severe, pressure-like substernal chest pain that is clinically indistinguishable from angina. It can also, importantly, respond to nitroglycerin, because nitrates relax smooth muscle throughout the body, not just in coronary vessels. A man who reports that his chest pain improved with nitroglycerin does not automatically have coronary artery disease.

A short trial of a proton pump inhibitor (PPI), typically given for two to four weeks, can help clarify whether acid reflux is contributing. If symptoms substantially resolve, a GI cause is more likely. If symptoms persist or if the presentation has any features that increase cardiac suspicion, cardiac workup should not be deferred.

Pleuritis and Pericarditis

Pleuritic chest pain is sharp and stabbing in character, worsens with deep inspiration, and is often positional. Many patients report that the pain improves when they sit forward. This pattern is distinct from ischemic pain, which is typically not affected by respiration or body position.

Pericarditis is the most important diagnosis in this category to identify, because it carries both a distinct treatment approach and the risk of being confused with an acute MI. The pain of pericarditis is pleuritic, often worse when lying flat, and improves dramatically when sitting forward. On physical examination, a pericardial friction rub may be heard; it is a high-pitched, scratching sound with two or three components per cardiac cycle. The ECG in pericarditis typically shows diffuse saddle-shaped ST elevation without the reciprocal changes seen in STEMI, along with PR depression in multiple leads.

If pericarditis is suspected, echo is warranted to evaluate for pericardial effusion, and serum troponin should be measured to assess for myopericarditis.

Anxiety and Panic Disorder

Chest pain from anxiety or panic attacks is common, particularly in younger men, and often presents with associated symptoms including shortness of breath, tingling in the hands or lips, a sense of impending doom, palpitations, and dizziness. The hyperventilation associated with panic attacks can cause secondary physiological changes, including coronary vasospasm in susceptible individuals.

A critical point: anxiety does not protect against ACS. A man who presents with chest pain and significant anxiety still needs an objective cardiac evaluation. Some clinicians mistakenly anchor on the psychological component and defer the cardiac workup, which is a pattern associated with missed MI. The two diagnoses can coexist, and a man with panic disorder can also develop coronary artery disease.

Aortic Dissection

Aortic dissection deserves separate emphasis because it is a diagnosis where early recognition is life-saving and where the clinical presentation can mislead. The pain of aortic dissection is typically described as tearing or ripping, reaches maximum intensity at its onset, and radiates to the back or between the shoulder blades. It is not a pain that builds gradually.

Key clinical findings that should raise suspicion include a blood pressure differential between arms, new aortic regurgitation murmur, pulse deficits, and a widened mediastinum on chest X-ray. In any man with this constellation, the appropriate initial imaging is CT angiography of the chest, abdomen, and pelvis with contrast. Thrombolytics and anticoagulation are contraindicated until dissection is excluded, because administering them in the setting of dissection can be fatal.

Risk Stratification Tools That Clinicians Use

The HEART Score

The HEART score is one of the most widely validated tools for triaging chest pain in emergency settings. It assigns points across five domains: History (how typical the presentation is for ACS), ECG (normal, nonspecific changes, or significant abnormality), Age (younger than 45, 45 to 64, or 65 and older), Risk factors (none, one to two, or three or more known risk factors), and Troponin (normal, 1 to 3 times the upper limit of normal, or more than 3 times normal).

A HEART score of 0 to 3 places a patient in the low-risk category, where the risk of major adverse cardiac events within 30 days is under 2 percent. A score of 4 to 6 is intermediate risk, and 7 to 10 is high risk. Guidelines recommend that low-risk patients may be appropriate for early discharge with close outpatient follow-up, while intermediate and high-risk patients warrant further evaluation and observation.

The TIMI score is also used in the context of known or suspected ACS to guide antiplatelet and anticoagulation decisions, though it is a prognostic tool in an already-diagnosed population rather than a triage tool for undifferentiated chest pain.

ECG Findings Every Man Should Know About

The 12-lead ECG is the most important immediate test in chest pain evaluation, but it must be interpreted in context. A normal ECG does not exclude ACS. Studies suggest that up to 6 percent of patients with normal or near-normal ECGs have confirmed MI.

ST elevation in a pattern consistent with a coronary territory, particularly with reciprocal changes in the opposite leads, indicates STEMI and requires emergent reperfusion. In most systems, this triggers the catheterization lab activation pathway without waiting for troponin results.

ST depression and T-wave inversions suggest myocardial ischemia or injury without complete occlusion, consistent with NSTEMI or unstable angina. These findings, particularly when dynamic (changing from one ECG to the next), carry high prognostic significance.

Left bundle branch block (LBBB) deserves special mention. New or presumably new LBBB in the setting of chest pain was historically treated as a STEMI equivalent, but this approach has been refined. The Sgarbossa criteria provide a validated framework for identifying STEMI in the presence of LBBB based on concordant ST changes, and the modified Sgarbossa criteria (using a ratio rather than absolute values) have improved sensitivity for this diagnosis.

High-Sensitivity Troponin and Serial Testing

High-sensitivity cardiac troponin assays have significantly changed the early evaluation of chest pain. These assays can detect myocardial injury at concentrations far below those detectable by earlier generation assays. The current evidence-based approach, endorsed by guidelines, involves serial troponin measurement at 0 and 1 to 3 hours (depending on the specific validated protocol used with each assay).

A rising troponin confirms myocardial injury. The absolute delta (the change between the first and second value) is often as diagnostically important as the absolute value. A single markedly elevated troponin is also significant.

Importantly, a single negative high-sensitivity troponin in a man with a low pre-test probability (low HEART score, no high-risk features) has a very high negative predictive value for MI, often above 99 percent in validated protocols. This has enabled earlier safe discharge from emergency departments in appropriately selected low-risk patients.

Stress Testing and Coronary CT Angiography

For men who present with chest pain that does not have high-risk features, where initial troponins are negative and the ECG is non-diagnostic, the question becomes how to evaluate for obstructive coronary artery disease in a safe and efficient way.

Exercise stress testing has been the traditional approach. The Duke Treadmill Score, which incorporates exercise duration, ST changes, and angina during testing, provides prognostic information beyond simply whether the test is “positive” or “negative.” However, exercise stress testing has limited sensitivity, particularly in men with single-vessel disease or in early CAD.

Coronary CT angiography (CTA) has become the preferred approach for intermediate-risk men with stable presentations. The PROMISE trial (Douglas et al., 2015, NEJM) demonstrated that a CT-guided initial strategy was non-inferior to functional testing for major adverse cardiac events in stable symptomatic patients, with the added benefit of identifying non-obstructive atherosclerosis that carries prognostic weight. The SCOT-HEART trial showed that CT coronary angiography guided management reduced the rate of subsequent MI compared to standard care in outpatient chest pain clinics.

Coronary CTA has a near-100 percent negative predictive value for obstructive CAD, meaning that a negative result in a man with intermediate pre-test probability is highly reassuring. Guidelines increasingly support CTA as a first-line test in men aged 40 to 65 who present with stable chest pain and intermediate pre-test probability for CAD.

When to Call Emergency Services Immediately

Some men with cardiac chest pain delay calling for help because they are unsure whether the symptoms are “serious enough.” The evidence shows that delays in presentation significantly worsen outcomes in STEMI, where every 30 minutes of additional ischemia time corresponds to measurable loss of myocardial function. The following presentations should prompt immediate emergency services activation without waiting to see if symptoms resolve:

Chest pain accompanied by diaphoresis, radiation to the arm or jaw, or new shortness of breath. Any chest pain lasting more than 15 minutes without clear relief. Pain that feels different in character or severity from any prior chest pain episode. Jaw or arm discomfort occurring without chest pain during exertion. These presentations are ACS until proven otherwise.

Pulling the Assessment Together

The most practical approach to chest pain in men treats cardiac ischemia as the default concern until objective evidence argues against it. The combination of clinical history (using a structured risk score like HEART), a 12-lead ECG, and serial high-sensitivity troponin at 0 and 1 to 3 hours provides the foundation for triage decisions. Non-cardiac features in the history, physical exam, and ECG can raise the probability of alternative diagnoses, but they should lower the threshold for cardiac workup, not serve as a reason to avoid it entirely.

For men who clear the initial high-risk evaluation and have a low HEART score, early discharge with outpatient follow-up and functional or anatomic testing is appropriate. For those with intermediate or high HEART scores, additional workup and observation in a monitored setting are warranted. For any man in whom aortic dissection is on the differential, immediate CT angiography takes precedence over all other testing.

Knowing which causes are cardiac and which are not matters less in the first hour than having a reliable system for ensuring the cardiac causes are not missed. That is what the evidence-based triage tools, serial troponins, and appropriate imaging are designed to do.

Key Takeaways

Approximately 30 to 40 percent of men with ACS present without the classic pressure-radiation-diaphoresis triad, so atypical presentations still require objective evaluation. The HEART score provides validated, structured risk stratification that guides disposition decisions in emergency settings. High-sensitivity troponin with serial measurement at 0 and 1 to 3 hours is the cornerstone of biomarker-based rule-out strategies. Coronary CTA has near-100 percent negative predictive value for obstructive CAD and is preferred in intermediate-risk men with stable chest pain. Aortic dissection must be considered when pain is tearing, maximal at onset, and radiates to the back; do not administer thrombolytics until this is excluded. Palpation-reproducible tenderness does not exclude cardiac ischemia. Anxiety and panic do not protect against ACS and should not substitute for objective cardiac evaluation.

The Signal Check is fifteen questions mapping the male cardiovascular risk pattern, including the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.